Oaktree Capital Management approves new term loan for Innocoll
Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, announced recently the successful refinancing of its existing term loan facility with a new $125 million term loan provided by funds managed by Oaktree Capital Management, L.P. (“Oaktree”). As per reports, the new term loan meaningfully strengthens Innocoll’s financial flexibility and […]
